Furthermore, we and others have shown that inhibiting the MYCN associate EZH2 or other enzymes that modify the chromatin landscape causes reactivation of CLU and other potential tumor suppressor genes in cancer cells with therapeutic effects (16, –, 18). Here, MYCN is linked to cancer.